Based on these numbers, testing MOG antibodies in patients with low probability of MOGAD, e.g. including all MS-caused ON and myelitis cases, would result in a significant number of false-positive MOG antibody results in patients with low positive MOG serotiters (Supplementary Table 12). This evidence concerns the gene MOG and myeloid sarcoma.